Clin Colon Rectal Surg 2009; 22(2): 084-093
DOI: 10.1055/s-0029-1223839
© Thieme Medical Publishers

Presacral Tumors: Diagnosis and Management

Imran Hassan1 , E. Dawn Wietfeldt1
  • 1Department of Surgery, Section of Colorectal Surgery, Southern Illinois University School of Medicine, Springfield, Illinois
Further Information

Publication History

Publication Date:
27 May 2009 (online)

ABSTRACT

Presacral tumors are uncommon lesions that can be difficult to diagnose because of their nonspecific presenting signs and symptoms. Cross-sectional imaging is essential in evaluating these lesions to determine the optimal surgical approach and the extent of resection. Surgery is the mainstay of treatment as it establishes the diagnosis and prevents the adverse consequences associated with malignant degeneration and secondary bacterial infection. The outcomes for patients with benign presacral tumors are favorable. Although there have been substantial improvements in the prognosis of patients with malignant presacral tumors, the development of newer adjuvant therapies are likely to further improve the oncologic outcomes of malignant presacral tumors such as chordomas and sarcomas.

REFERENCES

  • 1 Hobson K G, Ghaemmaghami V, Roe J P, Goodnight J E, Khatri V P. Tumors of the retrorectal space.  Dis Colon Rectum. 2005;  48(10) 1964-1974
  • 2 Uhlig B E, Johnson R L. Presacral tumors and cysts in adults.  Dis Colon Rectum. 1975;  18(7) 581-589
  • 3 Gordon P H. Retrorectal tumors. In: Gordon PH, Nivatvongs S Principles and Practice of Surgery for the Colon, Rectum and Anus. St. Louis, MO; Quality Medical Publishing 1999: 427-445
  • 4 Young-Fadok T M, Dozois E J. Retrorectal tumors. In: Yeo CJ Shackelford's Surgery of the Alimentary Tract. Philadelphia; Saunders 2007: 2299-2311
  • 5 Dozois E J, Jacofsky D J, Dozois R R. Presacral tumors. In: Wolff BG, Fleshman JW, Beck DE, et al The ASCRS Textbook of Colon and Rectal Surgery. New York; Springer 2007: 501-514
  • 6 Lev-Chelouche D, Gutman M, Goldman G et al.. Presacral tumors: a practical classification and treatment of a unique and heterogeneous group of diseases.  Surgery. 2003;  133(5) 473-478
  • 7 Abel M E, Nelson R, Prasad M L, Pearl R K, Orsay C P, Abcarian H. Parasacrococcygeal approach for the resection of retrorectal developmental cysts.  Dis Colon Rectum. 1985;  28(11) 855-858
  • 8 La Quaglia M P, Feins N, Eraklis A, Hendren W H. Rectal duplications.  J Pediatr Surg. 1990;  25(9) 980-984
  • 9 Woodfield J C, Chalmers A G, Phillips N, Sagar P M. Algorithms for the surgical management of retrorectal tumours.  Br J Surg. 2008;  95(2) 214-221
  • 10 Jao S W, Beart Jr R W, Spencer R J, Reiman H M, Ilstrup D M. Retrorectal tumors. Mayo Clinic experience, 1960-1979.  Dis Colon Rectum. 1985;  28(9) 644-652
  • 11 Oren M, Lorber B, Lee S H, Truex Jr R C, Gennaro A R. Anterior sacral meningocele: report of five cases and review of the literature.  Dis Colon Rectum. 1977;  20(6) 492-505
  • 12 Glasgow S C, Birnbaum E H, Lowney J K et al.. Retrorectal tumors: a diagnostic and therapeutic challenge.  Dis Colon Rectum. 2005;  48(8) 1581-1587
  • 13 Sobrado C W, Mester M, Simonsen O S, Justo C R, deAbreu J N, Habr-Gama A. Retrorectal tumors complicating pregnancy. Report of two cases.  Dis Colon Rectum. 1996;  39(10) 1176-1179
  • 14 Buchs N, Taylor S, Roche B. The posterior approach for low retrorectal tumors in adults.  Int J Colorectal Dis. 2007;  22(4) 381-385
  • 15 Böhm B, Milsom J W, Fazio V W, Lavery I C, Church J M, Oakley J R. Our approach to the management of congenital presacral tumors in adults.  Int J Colorectal Dis. 1993;  8(3) 134-138
  • 16 Wolpert A, Beer-Gabel M, Lifschitz O, Zbar A P. The management of presacral masses in the adult.  Tech Coloproctol. 2002;  6(1) 43-49
  • 17 Bax N M, van der Zee D C. The laparoscopic approach to sacrococcygeal teratomas.  Surg Endosc. 2004;  18(1) 128-130
  • 18 Casali P G, Messina A, Stacchiotti S et al.. Imatinib mesylate in chordoma.  Cancer. 2004;  101(9) 2086-2097
  • 19 Varga P P, Bors I, Lazary A. Sacral tumors and management.  Orthop Clin North Am. 2009;  40(1) 105-123, vii
  • 20 Hof H, Welzel T, Debus J. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma.  Onkologie. 2006;  29(12) 572-574
  • 21 Cody III H S, Marcove R C, Quan S H. Malignant retrorectal tumors: 28 years' experience at Memorial Sloan-Kettering Cancer Center.  Dis Colon Rectum. 1981;  24(7) 501-506
  • 22 Jackson R J, Gokaslan Z L. Spinal-pelvic fixation in patients with lumbosacral neoplasms.  J Neurosurg. 2000;  92(1, Suppl) 61-70
  • 23 Chen Y, Xu H, Li Y et al.. Laparoscopic resection of presacral teratomas.  J Minim Invasive Gynecol. 2008;  15(5) 649-651
  • 24 Konstantinidis K, Theodoropoulos G E, Sambalis G et al.. Laparoscopic resection of presacral schwannomas.  Surg Laparosc Endosc Percutan Tech. 2005;  15(5) 302-304
  • 25 Bergh P, Kindblom L G, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom J M. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients.  Cancer. 2000;  88(9) 2122-2134
  • 26 Casali P G, Stacchiotti S, Sangalli C, Olmi P, Gronchi A. Chordoma.  Curr Opin Oncol. 2007;  19(4) 367-370
  • 27 McMaster M L, Goldstein A M, Bromley C M, Ishibe N, Parry D M. Chordoma: incidence and survival patterns in the United States, 1973-1995.  Cancer Causes Control. 2001;  12(1) 1-11

Imran HassanM.D. 

Department of Surgery, Section of Colorectal Surgery, SIU School of Medicine

701 North Rutledge, P.O. Box 19638, Springfield, IL 62794

Email: ihassan@siumed.edu

    >